Smartwatch study aims to keep heart failure patients out of hospital
NCT ID NCT07411170
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study tests whether using a wearable device (like a smartwatch) to monitor patients remotely can help doctors adjust heart failure medications more effectively. It includes 400 adults with both heart failure and atrial fibrillation. The goal is to improve treatment and reduce hospital readmissions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AF - ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart failure care gets a Check-Up: study tests if sharing guidelines boosts treatment
- Cooling probe may shield esophagus during heart ablation for AF
- Could eccentric exercise be the key to stronger hearts?
- AI-Powered patch could replace ultrasound for heart checkups
- Could one blood thinner be enough after a heart attack? new trial aims to find out
- Heart failure drug shows promise in rebuilding damaged hearts